Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03989154

Primary Ovarian Insufficient Patients

The Prospective Cohort Study for Primary Ovarian Insufficient Patients was set up to investigate the short- and long-term health consequences in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, China.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–40 year

Sex eligibility

Female

Study type

Observational

Primary location

Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, 450052, China

Location status: Recruiting

Location contact

Zhiqin Bu, M.D.

CONTACT

[email protected]

15981978863

About this study

Premature ovarian insufficiency (POI) is a rare cause of infertility in women affecting 1% of the population. It is characterized by amenorrhea, hypoestrogenism and elevated gonadotrophin levels in women younger than 40 years of age. Other than the reproductive outcome of these patients, the short- and long-term health consequences are still unknown.

Since last decade, Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD) has been used in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory for Reproduction and Genetics. Information of patients (POI, PCOS, Endometriosis, azoospermia, ect) were recorded comprehensively. The current project plans to recruit POI participants in our center. Biological samples, questionnaires and short/long term health data will be collected. The study is aimed to provide evidence for POI prognosis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • younger than 40 years of age
  • at least four or more months of amenorrhea, two or more instances in which the serum FSH level is > 40 U/L (i.e., two inspections at intervals of 1 month or more), with an oestradiol level of <20pg/ml

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. FSH (Follicle stimulating hormone)

    Time frame: Change from Baseline FSH at each6 months

    mIU/mL

  2. LH (luteinizing hormone)

    Time frame: Change from Baseline LH at each6 months

    mIU/mL

  3. Estrogen

    Time frame: Change from Baseline Estrogen at each6 months

    pg/ml

  4. Progesterone

    Time frame: Change from Baseline Progesterone at each6 months

    ng/ml

Secondary outcomes

  1. Volume of uterus and ovary

    Time frame: Change from Baseline volume at each6 months

    Record the Length (mm)*Width (mm)*Height (mm) of uterus, and each ovary

Study contacts

Contact information is provided by the study sponsor or research team.

Lanlan Fang, M.D.

CONTACT

[email protected]

13673355291

Sponsors and collaborators

Lead sponsor

The First Affiliated Hospital of Zhengzhou University

Other

Registry information

Official study title

Prospective Cohort Study for Primary Ovarian Insufficient Patients in Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD)

Important dates

Study start
2010
Primary completion
2050
Study completion
2050
First posted
Jun 18, 2019
Registry last updated
Jun 19, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.